【レポートの概要（一部）】
1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 30)
4.1 Insulin Delivery Devices: Market Snapshot
4.2 Geographic Analysis: Market, By Type (2016)
4.3 Insulin Delivery Devices Market Size, By End User, 2016 vs 2021 (USD Billion)
4.4 Geographic Snapshot of the Market
5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Diabetic Population
5.2.1.2 Technological Advancements in Insulin Delivery Devices
5.2.1.3 Favorable Reimbursement Environment and Government Support in Selected Countries
5.2.1.4 Conferences, Meetings, and Congresses to Create Awareness About Insulin Delivery Devices
5.2.2 Restraints
5.2.2.1 Poor Reimbursement Structure in Developing Countries
5.2.2.2 Needle Anxiety in Patients to Affect the Growth of the Pen Needles and Syringes Market
5.2.2.3 Oral Insulin as an Alternative Drug Delivery Method
5.2.2.4 Issues Associated With the Reuse of Pen Needles and Infusion Sets
5.2.3 Opportunities
5.2.3.1 Increasing Research and Development Activities
5.2.3.2 Increasing Diabetes-Related Health Expenditure in Emerging Economies
5.2.3.3 Safety Needles
5.2.4 Challenge
5.2.4.1 Severe Shortage of Endocrinologists in the U.S.
6 Insulin Delivery Devices Market, By Type (Page No. – 42)
6.1 Introduction
6.2 Pens
6.2.1 Reusable Insulin Pens
6.2.2 Disposable Insulin Pens
6.3 Insulin Pumps
6.3.1 External/Tethered Pumps
6.3.2 Patch Pumps
6.4 Pen Needles
6.4.1 Standard Pen Needles
6.4.2 Safety Pen Needles
6.5 Insulin Syringes
6.6 Other Insulin Delivery Devices
7 Insulin Delivery Devices Market, By End User (Page No. – 60)
7.1 Introduction
7.2 Patients/Homecare
7.3 Hospitals & Clinics
8 Insulin Delivery Devices Market, By Region (Page No. – 65)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Diabetes and Favorable Reimbursement Scenario
8.2.1.2 Awareness Activities to Stimulate Usage of Insulin Delivery Devices in the U.S.
8.2.1.3 Growing Venture Capital Investments and Issuance of Ipos
8.2.1.4 FDA Approvals to Increase the Commercial Availability of Insulin Delivery Devices
8.2.2 Canada
8.2.2.1 High Prevalence of Diabetes and Favorable Reimbursement for Insulin Delivery Devices
8.2.2.2 Regulations for the Usage of Safety-Engineered Needles
8.3 Europe
8.3.1 Eu’s Directive on the Prevention of Sharps Injuries in Hospitals and the Healthcare Sector
8.3.2 Germany
8.3.2.1 High Prevalence of Diabetes, Favorable Reimbursement for Insulin Devices
8.3.3 France
8.3.3.1 High Insurance Coverage and Increasing Affordability
8.3.3.2 Conferences and Exhibitions
8.3.4 U.K.
8.3.4.1 Role of Diabetes U.K. in Research and Diabetes Care
8.3.4.2 Low Insulin Pump Penetration in the U.K.
8.3.5 Rest of Europe (RoE)
8.3.5.1 Spain: Regulations for Mandatory Use of Safety Needles, Large Diabetic Population
8.3.5.2 Italy: Regional Variations in Terms of Coverage and Benefits to Hinder Market Growth
8.3.5.3 Strong Presence of Major Insulin Delivery Device Manufacturers in RoE Countries
8.3.5.4 Large Diabetic Populations in Russia, Romania, Poland, and Portugal
8.4 Asia- Pacific
8.4.1 High Diabetes Incidence and Population in Asia-Pacific
8.4.2 Partnerships Among Global and Local Players in Asia-Pacific
8.4.3 Japan: High Adoption of Insulin Pens and Approval of Injectable Insulin
8.4.4 India: Low Penetration of Pen Needles & Pumps and Low Awareness to Restrain Market Growth
8.4.5 Government Initiatives in Singapore
8.4.6 Vietnam, A Potential Market for Insulin Delivery Devices
8.4.7 Australia: Amendments in Ndss to Broaden Patient Access to Diabetes Products
8.5 RoW
8.5.1 Increasing Diabetic Population
8.5.2 Rising Awareness on Diabetes
8.5.3 Conferences
9 Competitive Landscape (Page No. – 103)
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Marketing and Promotion
9.3.2 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations
9.3.3 Product Launches
9.3.4 Expansions
9.3.5 Other Strategies
10 Company Profiles (Page No. – 114)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 Introduction
10.2 Becton, Dickinson and Company
10.3 Novo Nordisk A/S
10.4 Medtronic PLC
10.5 Sanofi
10.6 ELI Lilly and Company
10.7 Ypsomed Holding AG
10.8 Animas Corporation (Johnson and Johnson)
10.9 Tandem Diabetes Care, Inc.
10.10 Insulet Corporation
10.11 Biocon Limited
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. – 136)
11.1 Discussion Guide
11.2 Other Developments
11.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.4 Introducing RT: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports
11.7 Author Details
List of Tables (100 Tables)
Table 1 10 Countries/Territories With the Highest Number of Diabetics (20–79 Years), 2015 & 2040
Table 2 FDA Approvals in the Insulin Delivery Devices Market (2014–2016)
Table 3 Conferences, Meetings, and Congresses Focusing on Insulin Delivery Devices (2014–2017)
Table 4 Global Market Size, By Type, 2014–2021 (USD Million)
Table 5 Global Market Size, By Type, 2014–2021 (Thousand Units)
Table 6 Pens Market Size, By Type, 2014–2021 (USD Million)
Table 7 Pens Market Size, By Type, 2014–2021 (Thousand Units)
Table 8 Pens Market Size, By Region, 2014–2021 (USD Million)
Table 9 Pens Market Size, By Region, 2014–2021 (Thousand Units)
Table 10 Reusable Insulin Pens Market Size, By Region, 2014–2021 (USD Million)
Table 11 Reusable Insulin Pens Market Size, By Region, 2014–2021 (Thousand Units)
Table 12 Disposable Insulin Pens Market Size, By Region, 2014–2021 (USD Million)
Table 13 Disposable Insulin Pens Market Size, By Region, 2014–2021 (Thousand Units)
Table 14 Insulin Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 15 Insulin Pumps Market Size, By Type, 2014–2021 (Thousand Units)
Table 16 Insulin Pumps Market Size, By Region, 2014–2021 (USD Million)
Table 17 Insulin Pumps Market Size, By Region, 2014–2021 (Thousand Units)
Table 18 External/Tethered Pumps Market Size, By Region, 2014–2021 (USD Million)
Table 19 External/Tethered Pumps Market Size, By Region, 2014–2021 (Thousand Units)
Table 20 Patch Pumps Market Size, By Region, 2014–2021 (USD Million)
Table 21 Patch Pumps Market Size, By Region, 2014–2021 (Thousand Units)
Table 22 Pen Needles Market Size, By Type, 2014–2021 (USD Million)
Table 23 Pen Needles Market Size, By Type, 2014–2021 (Thousand Units)
Table 24 Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 25 Pen Needles Market Size, By Region, 2014–2021 (Thousand Units)
Table 26 Standard Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 27 Standard Pen Needles Market Size, By Region, 2014–2021 (Thousand Units)
Table 28 Safety Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 29 Safety Pen Needles Market Size, By Region, 2014–2021 (Thousand Units)
Table 30 Insulin Syringes Market Size, By Region, 2014–2021 (USD Million)
Table 31 Insulin Syringes Market Size, By Region, 2014–2021 (Thousand Units)
Table 32 Other IDD Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other IDD Market Size, By Region, 2014–2021 (Thousand Units)
Table 34 Market Size, By End User, 2014-2021 (USD Million)
Table 35 Patients/Homecare Market Size, By Region, 2014-2021 (USD Million)
Table 36 Hospitals & Clinics Market Size, By Region, 2014-2021 (USD Million)
Table 37 Market Size, By Region, 2014-2021 (USD Million)
Table 38 North America: Insulin Delivery Devices Market Size, By Country, 2014-2021 (USD Million)
Table 39 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 40 North America: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 41 North America: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 42 North America: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 43 North America: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 44 Investements Made By Companies for Diabetes Management, 2015
Table 45 FDA Approvals for Insulin Delivery Devices (2013-2016)
Table 46 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 47 U.S.: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 48 U.S.: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 49 U.S.: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 50 U.S.: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 51 Eligibility for Insulin Pumps and Supplies in Canada for Type I Diabetes, March 2015
Table 52 Canada: Insulin Delivery Devices Market Size, By Type, 2014-2021 (USD Million)
Table 53 Canada: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 54 Canada: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 55 Canada: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 56 Canada: Market Size, By End User, 2014-2021 (USD Million)
Table 57 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 58 Europe: Market Size, By Type, 2014-2021 (USD Million)
Table 59 Europe: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 60 Europe: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 61 Europe: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 62 Europe: Market Size, By End User, 2014-2021 (USD Million)
Table 63 Germany: IDD Market Size, By Type, 2014-2021 (USD Million)
Table 64 Germany: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 65 Germany: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 66 Germany: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 67 Germany: Market Size, By End User, 2014-2021 (USD Million)
Table 68 France: Insulin Delivery Devices Market Size, By Type, 2014-2021 (USD Million)
Table 69 France: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 70 France: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 71 France: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 72 France: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 73 U.K.: Market Size, By Type, 2014-2021 (USD Million)
Table 74 U.K.: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 75 U.K.: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 76 U.K.: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 77 U.K.: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 78 Indicative List: Companies Headquartered in RoE Countries
Table 79 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 80 RoE: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 81 RoE: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 82 RoE: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 83 RoE: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 84 Diabetes Prevalence in Asia-Pacific, By Country
Table 85 Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 86 Asia-Pacific: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 87 Asia-Pacific: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 88 Asia-Pacific: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 89 Asia-Pacific: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 90 Conference in Africa, Brazil, and the Middle East (2015-2017)
Table 91 RoW: Insulin Delivery Devices Market Size, By Type, 2014-2021 (USD Million)
Table 92 RoW: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 93 RoW: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 94 RoW: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 95 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 96 Marketing and Promotion: Recent Developments (2014–2017)
Table 97 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations: Recent Developments (2014–2017)
Table 98 Product Launches: Recent Developments (2014–2017)
Table 99 Expansions: Recent Developments (2014–2017)
Table 100 Other Strategies: Recent Developments (2014–2017)
List of Figures (38 Figures)
Figure 1 Global Insulin Delivery Devices Market: Research Methodology Steps
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Research Design
Figure 5 Data Triangulation Methodology
Figure 6 Insulin Pens Segment Commanded the Largest Share of the Insulin Delivery Devices Market in 2016
Figure 7 Patients/Homecare Segment to Register the Highest CAGR in the Forecast Period
Figure 8 North America Commanded the Largest Share of the Insulin Delivery Devices Market in 2016
Figure 9 Asia-Pacific Offers Significant Growth Opportunities for Players in the Insulin Delivery Devices Market
Figure 10 Insulin Pens Accounted for the Largest Market Share in 2016
Figure 11 Patients/Homecare Segment Accounted for the Largest Share of the Insulin Delivery Devices Market in 2016
Figure 12 Asia-Pacific to Register the Highest Growth Rate in the Forecast Period (2016–2021)
Figure 13 Insulin Delivery Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 Pens Commanded the Largest Share in Insulin Delivery Devices Market in 2016
Figure 15 Patients/Homecare Segment to Command the Largest Share of the Insulin Delivery Devices End-User Market
Figure 16 North America: Insulin Delivery Devices Market Snapshot
Figure 17 Europe: Market Snapshot
Figure 18 Diabetes U.K.: Funds Raised vs Funds Invested
Figure 19 Comparison of Diabetes Cases, Related Deaths in European Countries, 2015
Figure 20 Asia-Pacific Market Snapshot
Figure 21 RoW Insulin Delivery Devices Market Snapshot
Figure 22 Growth Strategies, By Company
Figure 23 Market Share Analysis for Insulin Pens, By Key Player, 2016
Figure 24 Market Share Analysis for Insulin Pumps, By Key Player, 2016
Figure 25 Market Share Analysis for Pen Needles, By Key Player, 2016
Figure 26 Market Share Analysis for Syringes, By Key Player, 2016
Figure 27 Companies Adopted Marketing & Promotion as Key Growth Strategy From 2013 to 2016
Figure 28 Geographic Assessment of Players in the Insulin Delivery Devices Market
Figure 29 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 30 Novo Nordisk A/S: Company Snapshot (2016)
Figure 31 Medtronic PLC: Company Snapshot (2016)
Figure 32 Sanofi: Company Snapshot (2016)
Figure 33 ELI Lilly and Company: Company Snapshot (2015)
Figure 34 Ypsomed Holding AG: Company Snapshot (2015)
Figure 35 Johnson and Johnson: Company Snapshot (2016)
Figure 36 Tandem Diabetes Care, Inc.: Company Snapshot (2015)
Figure 37 Insulet Corporation: Company Snapshot (2015)
Figure 38 Biocon, Ltd.: Company Snapshot (2015)
【レポート販売概要】
■ タイトル：インスリン送達デバイスの世界市場予測（～2021年）：インスリンペン型注入器、インスリンポンプ、注射針、インスリン注射器■ 英文：Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021
■ 発行日：2017年4月24日
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-MD5192
■ 調査対象地域：グローバル
- デンタルサービスの世界市場：歯科インプラント、歯科矯正、美容歯科、歯周病サービスAbout the Dental Services Market Dental services market is one of the fastest emerging markets in the healthcare sector. It is one of the major revenue generators in the medical field, as it is regarded as one of the most expensive medical services being offered so far. The market is segmented based on the services offered and end-users for these dental services. Technavio’s analysts forecast the …
- ケモインフォマティックスの世界市場分析：製品別（全血算定、HGB / HCT検査、基本代謝パネル、BUNクレアチニン検査、電解質検査、HbA1c検査、包括的代謝パネル、肝臓パネル、腎パネル、脂質パネル）、セグメント予測、-2020The global market for clinical laboratory is expected to reach USD 148.82 billion by 2020, growing at an estimated CAGR of 6.8% from 2014 to 2020. Growing prevalence of chronic diseases and the development of novel laboratory testing methodologies is expected to drive the clinical laboratory tests market through to 2020. Due to the fact that results from clinical laboratory tests are the fundament …
- 世界における麻酔器の製品パイプライン動向2015Anesthesia Machines - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Anesthesia Machines - Pipeline Review, 2015" provides an overview of Anesthesia Machines currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players invol …
- 空気圧機器の世界市場：空気圧シリンダー、空気圧バルブ、空気動力エンジン及びモータAbout Pneumatic Equipment Pneumatic equipment uses compressed gas (air or any other inert gas) to produce mechanical motion. The equipment is used in volatile environments where hydraulic or electric tools cannot be used. It is also used in various industries such as Construction, Metallurgy, and Oil and Petrochemical. Pneumatic equipment is safer than electric and hydraulic tools and it is increa …
- ジェネリック医薬品の世界市場2016-2020About the Generic Drugs Market Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness …
- 世界のIGBT及びサイリスタ (Thyristor) 市場分析と予測（2013～2018）Electric power is the most essential component in human life, and life would come to a standstill without it. Thus, there is a need to enhance the transmission system. The IGBT & Thyristor market is in its growth stage and penetrating very fast. Since its invention in the early 1980s, the IGBT has become the dominant power of semiconductor in converters for mass transit applications. IGBT has beco …
- Lucentis (Microvascular Complications of Diabetes)：市場予測と分析（～2022）Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsel …
- PCR（ポリメラーゼ連鎖反応）利用パターン及び交換トレンドPCR is a well-adopted molecular diagnostics technique, and has a wide range of applications ranging from diagnosis of infectious disease, cancer, personalized medicine, and identification of target therapies for particular disease condition. This report provides qualitative assessment of the PCR technology in terms of pricing, replacement trends, competitors’ portfolio analysis, and selection crit …
- 劇場管理システム（TMS）の世界市場2016-2020About Theatre Management Systems A theater management system (TMS) refers to a software program that helps in the management of movie theaters. The software program offers centralized management of theater operations including schedule management, content distribution, playback monitoring, status monitoring, time management, and content management. Technavio’s analysts forecast the global TMS mark …
- 世界の殺ダニ剤（ダニ駆除薬）市場（～2019）Acaricides are chemical substances (organic/inorganic) that are used to kill ticks and mites. They are widely used in agriculture and animal husbandry to protect crops and cattle from mites and ticks (members of acarina). They are also found in animal products to protect pets such as cats and dogs from mites and ticks. The acaricides market is growing steadily due to increase in the demand of the …
- 芝生及び観賞植物用バイオスティミュラント（生物刺激剤）の世界市場The global agricultural bio stimulants in turf & ornamentals market is estimated to grow at a CAGR of 14.5% from 2014 to 2019. Countries, such as the U.S., Spain, and Italy held substantial share in the agricultural bio stimulants in turf & ornamentals market in 2013. Furthermore, the agricultural bio stimulants in turf & ornamentals market in Latin America is expected to grow at a CAGR of 15.6% f …
- 足・足首装具の世界市場About Foot and Ankle DevicesFoot and ankle devices are used for the correction and recuperation of the foot and ankle damaged by injuries or musculoskeletal disorders. The devices can also be used for orthopedic disorders such as osteoarthritis, osteoporosis, bunions, and hammertoes, as well as any congenital or neuropathic condition such as a diabetic foot that requires surgical/non-surgical corr …
- 肺動脈性肺高血圧症（PAH）治療薬の世界市場2017-2021About Pulmonary Arterial Hypertension (PAH) DrugsPAH in the arteries, which carry blood from the heart to the lungs, occurs when blood vessels become narrow, making blood flow difficult. Technavio’s analysts forecast the global pulmonary arterial hypertension drugs market to grow at a CAGR of 3.2% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the …
- ガラス焼き戻し装置の世界市場：タイプ別（化学処理、制御された熱的プロセス）、用途別（自動車産業、電子産業、建築・建設、その他）、地域別予測Global Glass Tempering System Market to reach USD 124.5 million by 2025. Global Glass Tempering System Market valued approximately USD 86 million in 2016 is anticipated to grow with a healthy growth rate of more than 4.20% over the forecast period 2017-2025. Toughened glass or tempered glass acquires a degree of strength of normal glass sheet which when broke, shatters into small and comparatively …
- 医療機器業界のM&A及び投資動向（四半期別）：Q4 2012Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q4 2012 Summary GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q4 2012” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financing in the medical equipment market. The report provides detailed information on M&As, equity/debt offerings, p …
